Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to ...

Ardelyx (ARDX) is rated Buy, driven by robust commercial execution of IBSRELA and XPHOZAH, and management's $1B revenue ...

Ardelyx (NASDAQ:ARDX) executives said the company entered 2026 with “another significant year of growth” underway, ...

Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...

(Chief Financial Officer Sue Hohenleitner) reported: “Our quarter-over-quarter total product revenues were $93.4 million compared to $67.8 million in the same period last year, representing 38% growth ...

Entropy Neurodynamics has reported 75% of patients achieved clinically meaningful symptom improvement in treatment-resistant ...

Surveyed HCPs identified reduction of days on TPN as a top priority –– Improved quality of life, lower risk of infection and thrombosis viewed as key benefits of reduced TPN dependence –– Additional ...

Have you ever wanted to wish on a star? Now is your chance, the Eta Aquarids peak this week — and here’s your guide to making ...

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Senior developmental and farm journalist Shree Padre said here on Friday that although two government research institutes ...

We’re all busy, and oftentimes good food choices fall beside the highway of life while we’re busy cruising. It’s just so easy ...

GLP-1s (short for “glucagon-like peptide-1 receptor agonists”) are medications that mimic a natural hormone in the body that helps to regulate blood sugar levels and appetite.